Related Experiment Videos

Comparative efficacy of dexamethasone versus hydrocortisone in severe acute pediatric asthma

Sedigheh Ebrahimi, Bahador Sarkari

    Iranian Journal of Allergy, Asthma, and Immunology
    |September 26, 2007
    PubMed

    Insights

    Dexamethasone significantly reduced hospitalization length for acute pediatric asthma compared to hydrocortisone. This finding supports dexamethasone as a more effective treatment option for children with severe asthma attacks.

    Area of Science:

    • Pediatric Pulmonology
    • Clinical Pharmacology
    • Emergency Medicine

    Background:

    • Acute pediatric asthma is a common respiratory emergency.
    • Corticosteroids are a mainstay treatment for moderate to severe asthma exacerbations in children.
    • Dexamethasone and hydrocortisone are commonly used corticosteroids, but their comparative efficacy in acute pediatric asthma requires further clarification.

    Purpose of the Study:

    • To compare the effectiveness of dexamethasone versus hydrocortisone in treating acute pediatric asthma.
    • To evaluate differences in hospitalization duration between the two corticosteroid treatment groups.
    • To provide evidence-based recommendations for corticosteroid selection in pediatric asthma management.

    Main Methods:

    • A randomized controlled trial involving 47 children with acute asthma.
    • Participants received either a single dose of dexamethasone (0.6 mg/ml, max 16 mg) or hydrocortisone (8-10 mg/kg/day) in 4 divided doses for 2 days.
    • The primary outcome measured was the length of hospital stay.

    Main Results:

    • Children treated with dexamethasone had a significantly shorter mean length of hospitalization compared to those who received hydrocortisone.
    • No other comparative efficacy metrics were detailed in the abstract.
    • The study included a sample size of 47 pediatric patients.

    Conclusions:

    • Single-dose dexamethasone appears more effective than a 2-day course of hydrocortisone in reducing hospitalization duration for acute pediatric asthma.
    • Dexamethasone may be a preferred corticosteroid for managing acute asthma exacerbations in children.
    • Further research is warranted to explore long-term outcomes and potential side effects.

    Related Concept Videos

    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

    Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

    Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
    ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
    COPD: Management Using Bronchodilators and Corticosteroids01:26

    COPD: Management Using Bronchodilators and Corticosteroids

    Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
    Asthma-IV: Diagnostic and Management01:30

    Asthma-IV: Diagnostic and Management

    The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
    Clinical Assessment for Asthma:
    This is the first step in diagnosing and managing asthma. It includes:
    Asthma III: Clinical Manifestations01:13

    Asthma III: Clinical Manifestations

    Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

    Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
    Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

    Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

    Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...